D-0049-2024 Class I Terminated
FDA drug recall D-0049-2024 was initiated by KVK-Tech, Inc. on Sep 20, 2023 and is designated Class I. Reason for recall: Presence of Foreign Tablets/Capsules: There is a potential presence of oxycodone HCl tablets, USP 5 mg in bottles. The recall status is terminated (terminated Jul 29, 2025). Affected quantity: 1488 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Oct 25, 2023
- Initiation Date
- Sep 20, 2023
- Termination Date
- Jul 29, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1488 bottles
Product description
Betaxolol Tablets, USP 10 mg, Rx Only, 100 count bottles, Mfd by: KVK Tech Inc., Newtown, PA 18940, Made in USA, NDC# 10702-013-01.
Reason for recall
Presence of Foreign Tablets/Capsules: There is a potential presence of oxycodone HCl tablets, USP 5 mg in bottles.
Distribution pattern
Nationwide in the USA and PR
Code information
Lot # 17853A, Exp. 06/30/2027
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0049-2024
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026